Last checked at 
(Sharecast News) - Feedback announced a significant development in its clinical infrastructure offerings on Wednesday, with radiology specialist Medical Imaging Partnership (MIP) agreeing to pilot Bleepa-CareLocker.
The AIM-traded firm said the initiative aimed to deliver multiple clinical pathways within the UK private healthcare sector.
It said the agreement would facilitate the evaluation of a pathway designed to streamline diagnostics and asynchronous multidisciplinary team (MDT) reviews, mirroring successful models used within the NHS.
Following an initial assessment period, the pilot would transition to a paid basis.
Bleepa would initially support various diagnostic-led clinical pathways, starting with a pioneering direct access prostate screening service by MIP, with plans for further pathways in cardiac and women's health services later in the year.
Although initial patient volumes and associated revenue were expected to be modest, the significance of the pilot is underscored by its translation of successful NHS pathways into the private healthcare sector.
"This exciting programme is the culmination of years of pathway work alongside UK clinicians," said chief executive officer Dr Tom Oakley.
"In Bleepa-CareLocker, we have developed a platform that delivers an unparalleled value proposition to clinical service partners, both in the NHS and now in the private sector."
Dr Oakley said it was the first time that the company had translated its NHS model into the private sector, adding that it was "excited" to see the impact that could have for private patients and MIP as its clinical service partner and customer.
"We hope to use this pilot to open our opportunity in the UK private healthcare market, which was expected to reach £11bn in 2023."
At 1153 GMT, shares in Feedback were up 1.61% at 63p.
Reporting by Josh White for Sharecast.com.
